27th International Epilepsy Congress


8 - 12 July 2007

Set to take place on July 8-12, 2007 in Singapore, the 27th International Epilepsy Congress will provide a vast array of educational sessions and networking opportunities.

The scientific and educational programs will cover over 40 cutting edge topics and provide clinical updates essential for continuing professional development of clinicians. The program will also be broad enough for clinicians who are non-epileptologists and allied health professionals involved in epilepsy care to attend.

The Joint Executive Committees of ILAE and IBE have selected seven main topics in the scientific program, which were based on recommendations received from ILAE and IBE chapters around the world.

The sessions will focus on the following topics:

Issues in Developing Countries
Acquisition and usage of new drugs, surgery, research, aetiologies, complementary therapies, establishment of national epilepsy centres, national programmes for capacity building and training, and other issues unique to the developing world will be discussed.
Nadir E. Bharucha, India

Treatment of Epilepsy
This topic will focus on issues related to drug and surgical treatments such as adequate therapeutic trials and medication failure for the purpose of epilepsy surgery, indication for surgery in nonmedically refractory patients, when and how to withdraw medications after successful surgery, what to do next if surgery fails.
Michael Baulac, France

Neuropsychological and Psychiatric Aspects
Neuropsychological and psychiatric dysfunctions are co-morbidities closely related to seizures/epilepsy, underlying pathology and/or treatment. Prevention, early detection and optimal treatment of these co-morbidities will be discussed.
Michael Saling, Australia

Men and Women with Epilepsy Throughout Life
Gender issues in different stages of life will be highlighted in this main topic. In addition, the age and sex-related clinical challenges, medico-legal and psychosocial issues will also be emphasized.
Johan Falk Pedersen, Norway

Stigma and Quality of Life
De-stigmatizing epilepsy is one of the prerequisites to improving the quality of life of people affected by epilepsy. In this section, physicians and social workers will share their experiences on how to achieve this common goal.
Carlos Acevedo, Chile

Epileptogenesis in Relation to Genetic Predisposition in Abnormal Brains
Transnational research data will be presented with a view to develop novel strategies for the prevention and treatment of mesial temporal lobe epilepsy and other types of epilepsy.
Anna Maria Vezzani, Italy

Epidemiology and Prognosis
Amongst the topics discussed, will be permanent remission, predictors for remission and refractoriness, and lessons learnt from untreated patients.
Allen Hauser, USA